Henry Schein, Inc. (HSIC) Stock Analysis
Healthcare · Medical Distribution
Sell if holding. Analyst target reached at $81.25 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak growth.
Henry Schein distributes healthcare products and services to dental and medical practitioners globally through Global Distribution/Value-Added Services, Global Specialty Products (implants, endodontics, orthopedics), and Global Technology (practice management software) segments,... Read more
Sell if holding. Analyst target reached at $81.25 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak growth. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.1/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-06-15Recent Developments — Henry Schein, Inc.
Latest news
- NEWS Henry Schein (HSIC) down 9.4% since last earnings report: Can it rebound? - MSN — MSN negative
- NEWS Henry Schein Inc. (HSIC): David Einhorn Is Buying This Health Stock - Yahoo Finance — Yahoo Finance positive
- NEWS Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term - Yahoo Finance — Yahoo Finance positive
- NEWS Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance — Yahoo Finance neutral
- NEWS Henry Schein (HSIC) reports next week: Wall Street expects earnings growth - MSN — MSN positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $81.25 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak growth. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $77.57. Score 5.1/10, moderate confidence.
Take-profit target: $80.53 (-0.9% upside). Prior stop was $77.57. Stop-loss: $77.57.
Analyst target reached - limited upside remaining; Weak growth; Overbought (RSI 80).
Henry Schein, Inc. trades at a P/E of 24.5 (forward 13.7). TrendMatrix value score: 5.9/10. Verdict: Sell.
24 analysts cover HSIC with a consensus score of 3.8/5. Average price target: $88.
What does Henry Schein, Inc. do?Henry Schein distributes healthcare products and services to dental and medical practitioners globally through Global...
Henry Schein distributes healthcare products and services to dental and medical practitioners globally through Global Distribution/Value-Added Services, Global Specialty Products (implants, endodontics, orthopedics), and Global Technology (practice management software) segments, serving over one million customers worldwide. Top 10 suppliers in distribution accounted for ~25% of aggregate purchases; single largest supplier ~4%. No single customer represents a material concentration.